Related Experiment Video

Updated: Aug 26, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Prognosis of infants of diabetic mothers in relation to neonatal hypoglycaemia

J C Haworth, K N McRae, L A Dilling

    Developmental Medicine and Child Neurology
    |August 1, 1976
    PubMed

    Insights

    Neonatal hypoglycemia in infants of diabetic mothers did not impact long-term neurological or intellectual outcomes. This study found no link between infant blood glucose levels and later developmental performance.

    Area of Science:

    • Neonatal care
    • Developmental pediatrics
    • Endocrinology

    Background:

    • Infants born to diabetic mothers are at risk for neonatal hypoglycemia.
    • The long-term effects of neonatal hypoglycemia on neurological and intellectual development remain a concern.

    Purpose of the Study:

    • To investigate the association between neonatal hypoglycemia in infants of diabetic mothers and their subsequent neurological and intellectual performance.
    • To identify potential risk factors for abnormal development in this cohort.

    Main Methods:

    • A prospective follow-up study of 37 infants of diabetic mothers (25 hypoglycemic, 12 non-hypoglycemic).
    • Assessment of physical, neurological, and developmental performance at an average age of 4.5 years.
    • Analysis of neonatal clinical data and maternal diabetes factors.

    Main Results:

    • 11 children showed abnormalities (generalized retardation, neurological issues, developmental delays), 3 were possibly abnormal, and 23 were normal.
    • Abnormalities could not be linked to neonatal blood glucose levels, hypoglycemia duration, or maternal diabetes factors.
    • Abnormal group had smaller head circumference at birth, but no difference at follow-up; children tended to be shorter.

    Conclusions:

    • Neonatal hypoglycemia in infants of diabetic mothers does not appear to cause brain damage affecting long-term neurological and intellectual outcomes.
    • Other factors, not identified in this study, may contribute to developmental issues in this population.

    More Related Videos

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

    Published on: November 20, 2015

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    Related Concept Videos

    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...